275 related articles for article (PubMed ID: 29904838)
1. OnabotulinumtoxinA for chronic migraine: a real-life Italian multicenter experience.
Vernieri F; Paolucci M; Altamura C; Pasqualetti P; Mastrangelo V; Pierangeli G; Cevoli S; D'Amico D; Grazzi L
Neurol Sci; 2018 Jun; 39(Suppl 1):171-172. PubMed ID: 29904838
[No Abstract] [Full Text] [Related]
2. OnabotulinumtoxinA in chronic migraine: long-term efficacy in a prophylactic medication free cohort.
Schiano di Cola F; Pari E; Caratozzolo S; Mancinelli C; Liberini P; Rao R; Padovani A
Neurol Sci; 2018 Jun; 39(Suppl 1):159-160. PubMed ID: 29904848
[No Abstract] [Full Text] [Related]
3. OnabotulinumtoxinA for chronic migraine.
Blumenfeld A; Evans RW
Headache; 2012 Jan; 52(1):142-8. PubMed ID: 22268776
[No Abstract] [Full Text] [Related]
4. OnabotulinumtoxinA for the treatment of chronic migraine not quite there. .
Torgovnick J
Cephalalgia; 2011 Feb; 31(3):377; author reply 378-9. PubMed ID: 21098110
[No Abstract] [Full Text] [Related]
5. What is changing in chronic migraine treatment? An algorithm for onabotulinumtoxinA treatment by the Italian chronic migraine group.
Sacco S; Russo A; Geppetti P; Grazzi L; Negro A; Tassorelli C; Tedeschi G; Martelletti P
Expert Rev Neurother; 2020 Dec; 20(12):1275-1286. PubMed ID: 32990477
[TBL] [Abstract][Full Text] [Related]
6. OnabotulinumtoxinA for treatment of chronic migraine: a response.
Dodick DW; Turkel CC; Degryse RE; Aurora SK; Silberstein SD; Lipton RB; Diener HC; Brin MF
Headache; 2011 Jun; 51(6):1005-8. PubMed ID: 21592099
[No Abstract] [Full Text] [Related]
7. OnabotulinumtoxinA (BOTOX®): a guide to its use in preventing headaches in adults with chronic migraine.
Lyseng-Williamson KA; Frampton JE
CNS Drugs; 2012 Aug; 26(8):717-23. PubMed ID: 22784019
[TBL] [Abstract][Full Text] [Related]
8. OnabotulinumtoxinA for treatment of chronic migraine: the unblinding problem.
Solomon S
Headache; 2013 May; 53(5):824-6. PubMed ID: 23465058
[No Abstract] [Full Text] [Related]
9. Botulinum neurotoxin A for chronic migraine headaches: does it work and how?
Cairns BE; Gazerani P
Pain Manag; 2014; 4(6):377-80. PubMed ID: 25494688
[No Abstract] [Full Text] [Related]
10. Effects of onabotulinumtoxinA treatment in chronic migraine patients with and without daily headache at baseline: results from the COMPEL Study.
Young WB; Ivan Lopez J; Rothrock JF; Orejudos A; Manack Adams A; Lipton RB; Blumenfeld AM
J Headache Pain; 2019 Feb; 20(1):12. PubMed ID: 30709333
[TBL] [Abstract][Full Text] [Related]
11. OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine.
Lipton RB; Varon SF; Grosberg B; McAllister PJ; Freitag F; Aurora SK; Dodick DW; Silberstein SD; Diener HC; DeGryse RE; Nolan ME; Turkel CC
Neurology; 2011 Oct; 77(15):1465-72. PubMed ID: 21956721
[TBL] [Abstract][Full Text] [Related]
12. Botox for chronic migraine.
Drug Ther Bull; 2011 Feb; 49(2):22-4; quiz iii-iv. PubMed ID: 21304165
[TBL] [Abstract][Full Text] [Related]
13. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.
Diener HC; Dodick DW; Aurora SK; Turkel CC; DeGryse RE; Lipton RB; Silberstein SD; Brin MF;
Cephalalgia; 2010 Jul; 30(7):804-14. PubMed ID: 20647171
[TBL] [Abstract][Full Text] [Related]
14. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.
Aurora SK; Dodick DW; Turkel CC; DeGryse RE; Silberstein SD; Lipton RB; Diener HC; Brin MF;
Cephalalgia; 2010 Jul; 30(7):793-803. PubMed ID: 20647170
[TBL] [Abstract][Full Text] [Related]
15. OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine over one year of treatment: Pooled results from the PREEMPT randomized clinical trial program.
Lipton RB; Rosen NL; Ailani J; DeGryse RE; Gillard PJ; Varon SF
Cephalalgia; 2016 Aug; 36(9):899-908. PubMed ID: 27288354
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin A and migraine surgery.
Guyuron B; Tucker T; Kriegler J
Plast Reconstr Surg; 2003 Oct; 112(5 Suppl):171S-173S; discussion 174S-176S. PubMed ID: 14504501
[No Abstract] [Full Text] [Related]
17. IncobotulinumtoxinA for Migraine: A Retrospective Case Series.
Kazerooni R; Lim J; Ashley Blake P; Lessig S
Clin Ther; 2015 Aug; 37(8):1860-4. PubMed ID: 26166734
[TBL] [Abstract][Full Text] [Related]
18. Wearing Off Response to OnabotulinumtoxinA in Chronic Migraine: Analysis in a Series of 193 Patients.
Quintas S; García-Azorín D; Heredia P; Talavera B; Gago-Veiga AB; Guerrero ÁL
Pain Med; 2019 Sep; 20(9):1815-1821. PubMed ID: 30657951
[TBL] [Abstract][Full Text] [Related]
19. CALCA and TRPV1 genes polymorphisms are related to a good outcome in female chronic migraine patients treated with OnabotulinumtoxinA.
Moreno-Mayordomo R; Ruiz M; Pascual J; Gallego de la Sacristana M; Vidriales I; Sobrado M; Cernuda-Morollon E; Gago-Veiga AB; Garcia-Azorin D; Telleria JJ; Guerrero AL
J Headache Pain; 2019 Apr; 20(1):39. PubMed ID: 31014225
[TBL] [Abstract][Full Text] [Related]
20. Effect of OnabotulinumtoxinA Injection on Depression in Chronic Migraine.
Maasumi K; Thompson NR; Kriegler JS; Tepper SJ
Headache; 2015 Oct; 55(9):1218-24. PubMed ID: 26381856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
